Prosonix is an innovative speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines by design
Apr 15, 2014
Prosonix and Mylan Enter Into Global Licensing Agreement for Generic Versions of Inhaled...
Jan 23, 2014
Prosonix Reports Positive Top-line Results from its Phase 2 Clinical Study with PSX1002 in...
Oct 7, 2013
Generics Bulletin profiles the exciting potential of Prosonix' respiratory pipeline and...
4-8 May 2014
Fajardo, Puerto Rico
16-21 May 2014
San Diego, CA, USA